Functional resistance of inflammatory macrophages to methotrexate in vitro.
The purpose of this study was to evaluate the effects of high and low therapeutic doses of methotrexate (MTX) on macrophage metabolism and function in vitro. Monolayers of elicited rat peritoneal macrophages (PM) were exposed to a wide range of MTX concentrations (10(-8) M-10(-3) M) for 24 or 48 hr and macrophage RNA and protein metabolism were evaluated by the incorporation of [3H]5-uridine and [14C]1-leucine, respectively, into trichloroacetic acid (TCA)-precipitable material. Macrophage functional activity was examined by measuring the uptake of [14C]Pseudomonas aeruginosa to assess phagocytosis and the release of 51Cr from antibody-coated [51Cr]sheep red blood cells (SRBC) to assess antibody-dependent cell-mediated cytotoxicity. Following a 24-hr incubation with 10(-3) M MTX, incorporation of [3H]5-uridine into PM monolayers was enhanced 79% when compared to control monolayers (p less than 0.005). Washout studies revealed that the stimulation of uridine incorporation was no longer observed by 24 hr following the removal of MTX from the culture medium. Incubation with 10(-3) M MTX for 48 hr returned uridine incorporation to control levels, although leucine incorporation into protein was reduced by 22% (p less than 0.01). The depression in leucine incorporation in the presence of 10(-3) M MTX was not reversed after the removal of MTX from the culture medium. Uptake of [14C]P. aeruginosa was not altered following a 24- or 48-hr incubation with either 10(-7) M or 10(-3) M MTX. Similarly, [51Cr]SRBC cytolysis was not affected by a 2-hr preincubation with and continuous exposure to between 10(-8) M and 10(-3) M MTX. These results demonstrate that incubation of inflammatory macrophages with clinically high doses of MTX can alter macrophage RNA and protein metabolism without producing demonstrable changes in macrophage functional activity.